Avricore Health Inc
Research Avricore Health Inc (AVCR) on Bullrun: market cap CAD 6.95M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAVCR
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyCAD
- Market capCAD 6.95M
- Financial periodQ1 2026
- RevenueCAD 44.32K
- Net income-CAD 204.89K
- Free cash flow-CAD 28.28K
- Gross margin-19.4%
Valuation Snapshot
latest market cap is CAD 6.95M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 533.88K | -CAD 1.86M | -CAD 904.30K | 44.6% | n/a | CAD 227.92K | n/a | CAD 389.56K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-17 | CAD 6.95M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Avricore Health Inc's market cap?
Avricore Health Inc's market capitalization is CAD 6.95M.
What does Avricore Health Inc do?
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.